Cargando…
251 Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781873/ http://dx.doi.org/10.1093/ofid/ofu052.117 |
| _version_ | 1783295060296597504 |
|---|---|
| author | Miller, Benjamin Wooley, Myra Hershberger, Ellie Steenbergen, Judith Busa, Bhavin Yuan, Guojun Mensah, Robert Friedland, Ian Alverdy, John |
| author_facet | Miller, Benjamin Wooley, Myra Hershberger, Ellie Steenbergen, Judith Busa, Bhavin Yuan, Guojun Mensah, Robert Friedland, Ian Alverdy, John |
| author_sort | Miller, Benjamin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5781873 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57818732018-03-01 251 Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study Miller, Benjamin Wooley, Myra Hershberger, Ellie Steenbergen, Judith Busa, Bhavin Yuan, Guojun Mensah, Robert Friedland, Ian Alverdy, John Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781873/ http://dx.doi.org/10.1093/ofid/ofu052.117 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Miller, Benjamin Wooley, Myra Hershberger, Ellie Steenbergen, Judith Busa, Bhavin Yuan, Guojun Mensah, Robert Friedland, Ian Alverdy, John 251 Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study |
| title | 251 Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study |
| title_full | 251 Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study |
| title_fullStr | 251 Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study |
| title_full_unstemmed | 251 Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study |
| title_short | 251 Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study |
| title_sort | 251 characteristics and outcomes of complicated intra-abdominal infections involving pseudomonas aeruginosa from a phase 3 ceftolozane/tazobactam study |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781873/ http://dx.doi.org/10.1093/ofid/ofu052.117 |
| work_keys_str_mv | AT millerbenjamin 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy AT wooleymyra 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy AT hershbergerellie 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy AT steenbergenjudith 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy AT busabhavin 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy AT yuanguojun 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy AT mensahrobert 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy AT friedlandian 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy AT alverdyjohn 251characteristicsandoutcomesofcomplicatedintraabdominalinfectionsinvolvingpseudomonasaeruginosafromaphase3ceftolozanetazobactamstudy |